Correlation Between Morgan Stanley and Gilead Sciences

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Gilead Sciences, you can compare the effects of market volatilities on Morgan Stanley and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Gilead Sciences.

Diversification Opportunities for Morgan Stanley and Gilead Sciences

0.8

Correlation Coefficient

Morgan Stanley  Gilead Sciences

Very poor diversification

The 3 months correlation between Morgan and Gilead is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Gilead Sciences go up and down completely randomly.

Pair Corralation between Morgan Stanley and Gilead Sciences

Given the investment horizon of 90 days Morgan Stanley is expected to generate 67.52 times less return on investment than Gilead Sciences. But when comparing it to its historical volatility, Morgan Stanley Direct is 1.38 times less risky than Gilead Sciences. It trades about 0.0 of its potential returns per unit of risk. Gilead Sciences is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  18,921  in Gilead Sciences on September 26, 2024 and sell it today you would earn a total of  9,835  from holding Gilead Sciences or generate 51.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Morgan Stanley Direct  vs.  Gilead Sciences

Morgan Stanley Direct

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Gilead Sciences

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, Gilead Sciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and Gilead Sciences

The main advantage of trading using opposite Morgan Stanley and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.

The idea behind Morgan Stanley Direct and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.